Top Markets
#1 Black Phoenix Black Phoenix +858.95%
#2 QuantixAI QuantixAI +102.43%
#3 Nesa Nesa +41.16%
#4 MetaDAO MetaDAO +26.91%
#5 Pons Pons +25.33%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +21.23%
#7 LayerZero LayerZero +20.52%
#8 Bedrock Bedrock +19.21%
#9 Ontology Gas Ontology Gas +15.76%
#10 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +15.33%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Pharmaron Beijing Co., Ltd. Pharmaron Beijing Co., Ltd.

Pharmaron Beijing Co., Ltd.

300759
Classement en actions #2166
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a... Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Prix de l'action
$6.73
Capitalisation boursière
$9.94B
Changement (1 jour)
3.48%
Changement (1 an)
51.19%
Pays
CN
Échange Pharmaron Beijing Co., Ltd. (300759)

Catégorie

Healthcare
Bénéfices pour Pharmaron Beijing Co., Ltd. (300759)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Pharmaron Beijing Co., Ltd., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Pharmaron Beijing Co., Ltd. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH